National Mantle Cell Lymphoma Trial - Phase II Randomized Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 14 Jun 2023

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Rituximab (Primary) ; Cyclophosphamide; Cyclophosphamide; Fludarabine; Fludarabine
Indications Mantle-cell lymphoma
Focus Adverse reactions; Therapeutic Use

20 Dec 2012 Additional lead trial centre identified as reported by United Kingdom Clinical Research Network.
05 Nov 2009 Additional lead trial centre, trial locations identified as reported by United Kingdom Clinical Research Network record.
05 Nov 2009 New source identified and integrated (United Kingdom Clinical Research Network).

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com